| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1177/0145721706294259 |
| P698 | PubMed publication ID | 17102158 |
| P2093 | author name string | Catherine Carver | |
| P2860 | cites work | Oral Antidiabetic Agents | Q22241436 |
| Mechanisms of nutritional and hormonal regulation of lipogenesis | Q24522517 | ||
| Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 | ||
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| The prevalence of comorbid depression in adults with diabetes: a meta-analysis | Q28190708 | ||
| Neuroendocrine mechanisms regulating food intake and body weight | Q28214802 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
| Effects of insulin on muscle tissue | Q33821452 | ||
| Overweight, obesity, and health risk | Q33890013 | ||
| Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study | Q34720231 | ||
| Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies | Q35559800 | ||
| The management of the obese diabetic patient | Q35563453 | ||
| Barriers to following dietary recommendations in Type 2 diabetes | Q39703247 | ||
| Obesity treatment: can diet composition play a role? | Q40841369 | ||
| The prevention and treatment of obesity. Application to type 2 diabetes | Q41629185 | ||
| Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial | Q42625907 | ||
| NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance | Q42651177 | ||
| Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus | Q43626381 | ||
| American Diabetes Association position statement: evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications | Q43856679 | ||
| Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial | Q44007390 | ||
| A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin | Q44262737 | ||
| Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes | Q44295713 | ||
| Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart | Q44333388 | ||
| Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study | Q44333491 | ||
| Relationship of depression and diabetes self-care, medication adherence, and preventive care | Q44424523 | ||
| Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. | Q44671124 | ||
| Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. | Q44912980 | ||
| Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen | Q44953752 | ||
| Glycemic control in diabetic patients after bariatric surgery | Q45103166 | ||
| Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. | Q45124160 | ||
| Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes | Q45124469 | ||
| Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes | Q45218158 | ||
| Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin | Q45218162 | ||
| Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus | Q46412934 | ||
| Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes | Q46906811 | ||
| Role of brain insulin receptor in control of body weight and reproduction | Q47229086 | ||
| Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus | Q47237828 | ||
| Weight gain as a risk factor for clinical diabetes mellitus in women | Q47356176 | ||
| Intensive insulin therapy and weight gain in IDDM. | Q47384200 | ||
| Weight as a risk factor for clinical diabetes in women | Q47442215 | ||
| Behavioral and clinical factors associated with depression among individuals with diabetes | Q47871782 | ||
| Well-being and symptoms in relation to insulin therapy in type 2 diabetes | Q48008314 | ||
| Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. | Q51552638 | ||
| Early and long-term effects of acute caloric deprivation in obese diabetic patients. | Q51625052 | ||
| Diminished effect of caloric restriction on control of hyperglycemia with increasing known duration of type II diabetes mellitus. | Q51654148 | ||
| American College of Sports Medicine position stand. Exercise and type 2 diabetes. | Q52890563 | ||
| Insulin resistance and depression: Authors' reply. | Q55191764 | ||
| Depression and Diabetes: A large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes | Q58001950 | ||
| P433 | issue | 6 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| weight gain | Q3403879 | ||
| P304 | page(s) | 910-917 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | The Science of Diabetes Self-Management and Care | Q7730051 |
| P1476 | title | Insulin treatment and the problem of weight gain in type 2 diabetes | |
| P478 | volume | 32 |
| Q51244521 | A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes |
| Q39079377 | A review of the carbohydrate-insulin model of obesity |
| Q37505552 | Antidiabetic medications and weight gain: implications for the practicing physician |
| Q48160690 | Comparison between sodium-glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta-analysis. |
| Q38441105 | Cost effectiveness of adding dapagliflozin to insulin for the treatment of type 2 diabetes mellitus in the Netherlands |
| Q38815279 | Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China |
| Q41349411 | Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes. |
| Q37795873 | Early clinical studies with liraglutide |
| Q37831911 | Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus |
| Q37018165 | Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus |
| Q91992069 | Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetes |
| Q38494601 | Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy |
| Q37929744 | Emerging GLP-1 receptor agonists |
| Q44500493 | Energy loss via urine and faeces--a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight |
| Q33932057 | Evolving trends in insulin delivery in pursuit of improvements in diabetes management |
| Q33996818 | Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes |
| Q37355685 | Factors associated with weight loss after gastric bypass |
| Q35242207 | Four-year weight losses in the Look AHEAD study: factors associated with long-term success |
| Q37279276 | Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial |
| Q35894554 | Initiating insulin in patients with type 2 diabetes. |
| Q35769593 | Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin. |
| Q35703041 | Insulin detemir for the treatment of obese patients with type 2 diabetes |
| Q37199318 | Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine |
| Q37222569 | Insulin use and weight maintenance in well-controlled type 2 diabetes: a prospective cohort study |
| Q48353746 | Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus |
| Q36575356 | Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial |
| Q38811478 | New directions for diabetes prevention and management in behavioral medicine |
| Q37212232 | One-year weight losses in the Look AHEAD study: factors associated with success |
| Q42118984 | Painful and Prolonged Muscle Cramps following Insulin Injections in a Patient with Type 2 Diabetes Mellitus: Revisiting the 1992 Duke Case. |
| Q37364896 | Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing |
| Q39808718 | Prediction of excessive weight gain in insulin treated patients with type 2 diabetes |
| Q37336667 | Psychological insulin resistance: patient beliefs and implications for diabetes management |
| Q37815511 | Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir |
| Q50317671 | Rhinacanthins-rich Extract Enhances Glucose Uptake and Inhibits Adipogenesis in 3T3-L1 Adipocytes and L6 Myotubes. |
| Q40550581 | Sodium-glucose co-transporter 2 inhibitors in addition to insulin therapy for management of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials |
| Q38687258 | Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidences |
| Q30365939 | The entero-insular axis: implications for human metabolism. |
| Q43865591 | Therapeutic inertia in type 2 diabetes: insights from the PANORAMA study in France |
Search more.